Microbiology

  1. D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity

    1. Jie Hu
    2. Chang-Long He
    3. Qing-Zhu Gao
    4. Gui-Ji Zhang
    5. Xiao-Xia Cao
    6. Quan-Xin Long
    7. Hai-Jun Deng
    8. Lu-Yi Huang
    9. Juan Chen
    10. Kai Wang
    11. Ni Tang
    12. Ai-Long Huang

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  2. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

    1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses
    2. Alexander E. Gorbalenya
    3. Susan C. Baker
    4. Ralph S. Baric
    5. Raoul J. de Groot
    6. Christian Drosten
    7. Anastasia A. Gulyaeva
    8. Bart L. Haagmans
    9. Chris Lauber
    10. Andrey M. Leontovich
    11. Benjamin W. Neuman
    12. Dmitry Penzar
    13. Stanley Perlman
    14. Leo L. M. Poon
    15. Dmitry V. Samborskiy
    16. Igor A. Sidorov
    17. Isabel Sola
    18. John Ziebuhr

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  3. Self-assembling SARS-CoV-2 nanoparticle vaccines targeting the S protein induces protective immunity in mice

    1. Xingjian Liu
    2. Haozhi Song
    3. Jianmin Jiang
    4. Xintao Gao
    5. Yongzhu Yi
    6. Yuting Shang
    7. Jialei Li
    8. Dan Li
    9. Zhen Zeng
    10. Yinü Li
    11. Zhifang Zhang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes

    1. Daniel Todt
    2. Toni Luise Meister
    3. Barbora Tamele
    4. John Howes
    5. Dajana Paulmann
    6. Britta Becker
    7. Florian H. Brill
    8. Mark Wind
    9. Jack Schijven
    10. Natalie Heinen
    11. Volker Kinast
    12. Baxolele Mhlekude
    13. Christine Goffinet
    14. Adalbert Krawczyk
    15. Jörg Steinmann
    16. Stephanie Pfaender
    17. Yannick Brüggemann
    18. Eike Steinmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Capillary electrophoresis of PCR fragments with 5´-labelled primers for testing the SARS-Cov-2

    1. Juan Gómez
    2. Santiago Melón
    3. José A. Boga
    4. Marta E. Alvarez-Argüelles
    5. Susana Rojo-Alba
    6. Alvaro Leal-Negredo
    7. Cristian Castello-Abietar
    8. Victoria Alvarez
    9. Elías Cuesta-Llavona
    10. Eliecer Coto

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Quantitative proteomics of hamster lung tissues infected with SARS‐CoV‐2 reveal host factors having implication in the disease pathogenesis and severity

    1. Voddu Suresh
    2. Varshasnata Mohanty
    3. Kiran Avula
    4. Arup Ghosh
    5. Bharati Singh
    6. Rajendra Kumar Reddy
    7. Deepti Parida
    8. Amol Ratnakar Suryawanshi
    9. Sunil Kumar Raghav
    10. Soma Chattopadhyay
    11. Punit Prasad
    12. Rajeeb Kumar Swain
    13. Rupesh Dash
    14. Ajay Parida
    15. Gulam Hussain Syed
    16. Shantibhusan Senapati

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Identification of the SHREK Family of Proteins as Broad-Spectrum Host Antiviral Factors

    1. Deemah Dabbagh
    2. Sijia He
    3. Brian Hetrick
    4. Linda Chilin
    5. Ali Andalibi
    6. Yuntao Wu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies

    1. Frauke Muecksch
    2. Yiska Weisblum
    3. Christopher O. Barnes
    4. Fabian Schmidt
    5. Dennis Schaefer-Babajew
    6. Julio C C Lorenzi
    7. Andrew I Flyak
    8. Andrew T DeLaitsch
    9. Kathryn E Huey-Tubman
    10. Shurong Hou
    11. Celia A. Schiffer
    12. Christian Gaebler
    13. Zijun Wang
    14. Justin Da Silva
    15. Daniel Poston
    16. Shlomo Finkin
    17. Alice Cho
    18. Melissa Cipolla
    19. Thiago Y. Oliveira
    20. Katrina G. Millard
    21. Victor Ramos
    22. Anna Gazumyan
    23. Magdalena Rutkowska
    24. Marina Caskey
    25. Michel C. Nussenzweig
    26. Pamela J. Bjorkman
    27. Theodora Hatziioannou
    28. Paul D. Bieniasz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease

    1. James Brett Case
    2. Rita E. Chen
    3. Longxing Cao
    4. Baoling Ying
    5. Emma S. Winkler
    6. Max Johnson
    7. Inna Goreshnik
    8. Minh N. Pham
    9. Swathi Shrihari
    10. Natasha M. Kafai
    11. Adam L. Bailey
    12. Xuping Xie
    13. Pei-Yong Shi
    14. Rashmi Ravichandran
    15. Lauren Carter
    16. Lance Stewart
    17. David Baker
    18. Michael S. Diamond

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model

    1. Pierre Bessière
    2. Marine Wasniewski
    3. Evelyne Picard-Meyer
    4. Alexandre Servat
    5. Thomas Figueroa
    6. Charlotte Foret-Lucas
    7. Amelia Coggon
    8. Sandrine Lesellier
    9. Frank Boué
    10. Nathan Cebron
    11. Blandine Gausserès
    12. Catherine Trumel
    13. Gilles Foucras
    14. Francisco J. Salguero
    15. Elodie Monchatre-Leroy
    16. Romain Volmer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 199 of 248 Next